Cannabis medicine company unveils floatation plans

Investors are poised for a new high on the London market after a company which specialises in cannabis unveiled plans to float today.

GW Pharmaceuticals, the only company to legally develop and produce cannabis-based drugs, is seeking admission to the Alternative Investment Market at the end of June.